• SENSEX
    NIFTY 50

India sales boosts pharma earnings in Q3; US markets remains a key concern: CLSA

Updated : February 19, 2021 04:55 PM IST

According to CLSA, eleven pharma companies’ revenue rose 8.3 percent YoY to Rs 423 billion, a 3 percent miss.
Adjusted profits rose in the double digits YoY for a fourth quarter, spiking 45 percent YoY to Rs 61.6 billion, an 11 percent beat.
India sales boosts pharma earnings in Q3; US markets remains a key concern: CLSA
Published : February 19, 2021 04:48 PM IST

You May Also Like

Live TV

recommended for you

Advertisement